IL101397A - Single-stranded circular oligonucleotides capable of binding to a target dna or rna methods for the use thereof and pharmaceutical compositions containing them - Google Patents
Single-stranded circular oligonucleotides capable of binding to a target dna or rna methods for the use thereof and pharmaceutical compositions containing themInfo
- Publication number
- IL101397A IL101397A IL10139792A IL10139792A IL101397A IL 101397 A IL101397 A IL 101397A IL 10139792 A IL10139792 A IL 10139792A IL 10139792 A IL10139792 A IL 10139792A IL 101397 A IL101397 A IL 101397A
- Authority
- IL
- Israel
- Prior art keywords
- binding
- pharmaceutical compositions
- compositions containing
- target dna
- stranded circular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6839—Triple helix formation or other higher order conformations in hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C12N2310/152—Nucleic acids forming more than 2 strands, e.g. TFOs on a single-stranded target, e.g. fold-back TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
- C12N2310/3183—Diol linkers, e.g. glycols or propanediols
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67584391A | 1991-03-27 | 1991-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL101397A0 IL101397A0 (en) | 1992-11-15 |
IL101397A true IL101397A (en) | 1997-01-10 |
Family
ID=24712177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10139792A IL101397A (en) | 1991-03-27 | 1992-03-27 | Single-stranded circular oligonucleotides capable of binding to a target dna or rna methods for the use thereof and pharmaceutical compositions containing them |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0579771A4 (en) |
JP (1) | JPH06506603A (en) |
AU (1) | AU661490B2 (en) |
CA (1) | CA2105864A1 (en) |
FI (1) | FI934192A (en) |
HU (1) | HUT66828A (en) |
IE (1) | IE920981A1 (en) |
IL (1) | IL101397A (en) |
NO (1) | NO933410L (en) |
WO (1) | WO1992017484A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683874A (en) * | 1991-03-27 | 1997-11-04 | Research Corporation Technologies, Inc. | Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence |
FR2675803B1 (en) * | 1991-04-25 | 1996-09-06 | Genset Sa | CLOSED, ANTISENSE AND SENSE OLIGONUCLEOTIDES AND THEIR APPLICATIONS. |
IL107934A0 (en) * | 1992-12-08 | 1994-04-12 | Genta Inc | Formation of triple helix complexes |
US6096880A (en) * | 1993-04-15 | 2000-08-01 | University Of Rochester | Circular DNA vectors for synthesis of RNA and DNA |
US7135312B2 (en) | 1993-04-15 | 2006-11-14 | University Of Rochester | Circular DNA vectors for synthesis of RNA and DNA |
US6077668A (en) * | 1993-04-15 | 2000-06-20 | University Of Rochester | Highly sensitive multimeric nucleic acid probes |
US5714320A (en) * | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
US5473060A (en) * | 1993-07-02 | 1995-12-05 | Lynx Therapeutics, Inc. | Oligonucleotide clamps having diagnostic applications |
US5674683A (en) * | 1995-03-21 | 1997-10-07 | Research Corporation Technologies, Inc. | Stem-loop and circular oligonucleotides and method of using |
ES2109177B1 (en) * | 1995-10-11 | 1998-07-16 | Univ Barcelona | GENERAL PROCEDURE FOR THE PREPARATION OF CYCLIC AND INTERMEDIATE OLIGONUCLEOTIDES FOR THE SAME. |
US20050059016A1 (en) * | 2002-11-05 | 2005-03-17 | Ecker David J. | Structural motifs and oligomeric compounds and their use in gene modulation |
US7138384B1 (en) | 1997-08-29 | 2006-11-21 | The Regents Of The University Of California | Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
DK1034262T3 (en) | 1997-11-18 | 2005-11-28 | Pioneer Hi Bred Int | Compositions and Methods for Genetic Modification of Plants |
EP1032692A1 (en) * | 1997-11-18 | 2000-09-06 | Pioneer Hi-Bred International, Inc. | Targeted manipulation of herbicide-resistance genes in plants |
US7102055B1 (en) | 1997-11-18 | 2006-09-05 | Pioneer Hi-Bred International, Inc. | Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant |
EP1112378A1 (en) * | 1998-07-17 | 2001-07-04 | GeneTag Technology, Inc. | Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
US7560622B2 (en) | 2000-10-06 | 2009-07-14 | Pioneer Hi-Bred International, Inc. | Methods and compositions relating to the generation of partially transgenic organisms |
JP2005102502A (en) * | 2001-11-21 | 2005-04-21 | Wakunaga Pharmaceut Co Ltd | Method for amplifying single-stranded nucleic acid fragment |
EP1986697B1 (en) * | 2006-02-17 | 2016-06-29 | GE Healthcare Dharmacon, Inc. | Compositions and methods for inhibiting gene silencing by rna interference |
WO2008017473A2 (en) | 2006-08-08 | 2008-02-14 | Gunther Hartmann | Structure and use of 5' phosphate oligonucleotides |
JP5540312B2 (en) * | 2008-02-15 | 2014-07-02 | 独立行政法人理化学研究所 | Circular single-stranded nucleic acid complex and method for producing the same |
JP5689413B2 (en) | 2008-05-21 | 2015-03-25 | ライニッシュ フリードリッヒ−ウィルヘルムズ−ユニバーシタット ボン | 5 'triphosphate oligonucleotide having blunt ends and uses thereof |
EP2508530A1 (en) | 2011-03-28 | 2012-10-10 | Rheinische Friedrich-Wilhelms-Universität Bonn | Purification of triphosphorylated oligonucleotides using capture tags |
EP2712870A1 (en) | 2012-09-27 | 2014-04-02 | Rheinische Friedrich-Wilhelms-Universität Bonn | Novel RIG-I ligands and methods for producing them |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1228811A (en) * | 1983-05-05 | 1987-11-03 | Robert G. Pergolizzi | Assay method utilizing polynucleotide sequences |
US4766062A (en) * | 1984-05-07 | 1988-08-23 | Allied Corporation | Displacement polynucleotide assay method and polynucleotide complex reagent therefor |
-
1992
- 1992-03-26 AU AU19874/92A patent/AU661490B2/en not_active Ceased
- 1992-03-26 CA CA002105864A patent/CA2105864A1/en not_active Abandoned
- 1992-03-26 JP JP4511673A patent/JPH06506603A/en active Pending
- 1992-03-26 HU HU9302708A patent/HUT66828A/en unknown
- 1992-03-26 EP EP92912127A patent/EP0579771A4/en not_active Withdrawn
- 1992-03-26 WO PCT/US1992/002480 patent/WO1992017484A1/en not_active Application Discontinuation
- 1992-03-27 IE IE098192A patent/IE920981A1/en unknown
- 1992-03-27 IL IL10139792A patent/IL101397A/en not_active IP Right Cessation
-
1993
- 1993-09-24 NO NO933410A patent/NO933410L/en unknown
- 1993-09-24 FI FI934192A patent/FI934192A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0579771A4 (en) | 1997-06-11 |
CA2105864A1 (en) | 1992-09-28 |
HU9302708D0 (en) | 1994-01-28 |
AU661490B2 (en) | 1995-07-27 |
EP0579771A1 (en) | 1994-01-26 |
AU1987492A (en) | 1992-11-02 |
FI934192A0 (en) | 1993-09-24 |
HUT66828A (en) | 1995-01-30 |
JPH06506603A (en) | 1994-07-28 |
IL101397A0 (en) | 1992-11-15 |
FI934192A (en) | 1993-09-24 |
NO933410D0 (en) | 1993-09-24 |
NO933410L (en) | 1993-11-26 |
IE920981A1 (en) | 1992-10-07 |
WO1992017484A1 (en) | 1992-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL101397A (en) | Single-stranded circular oligonucleotides capable of binding to a target dna or rna methods for the use thereof and pharmaceutical compositions containing them | |
US5446137B1 (en) | Oligonucleotides containing 4'-substituted nucleotides | |
EP0554376A4 (en) | Dna construct for providing rna therapy | |
EP0521108A4 (en) | Site specific cleavage of single-stranded dna | |
CA2089666A1 (en) | Oligonucleotides for modulating the effects of cytomegalovirus infections | |
IL127955A0 (en) | Pharmaceutical composition containing acid addition salt of basic drug | |
AU2028792A (en) | Sequence specific dna binding drugs | |
IL86518A0 (en) | Nourishing products containing nucleosides and/or nucleotides and processes for the preparation thereof | |
PL312836A1 (en) | Variations of family b of dna polymerase used for dna sequencing | |
HUP9801207A3 (en) | Therapeutic compositions for transfecting nucleic acids and use thereof | |
ZA908653B (en) | Site specific modification of the candida tropicalis genome | |
GB9311386D0 (en) | Nucleic acid analogue assay procedures | |
HUP0202338A3 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
WO1989011211A3 (en) | Oligonucleotide bank and process for dna sequencing | |
EP0574267A3 (en) | Preparation of nucleic acid from blood | |
HUP0002037A3 (en) | Hydroximic acid derivatives, use of them for producing pharmaceutical compositions suitable for inhibiting matrix metalloproteinas and pharmaceutical compositions containing the compounds | |
EP0558944A3 (en) | Rna and dna molecules for producing virus resistance | |
ZA9557B (en) | Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them | |
EP0517515A3 (en) | Method of purifying dna | |
HUP0002622A3 (en) | Pharmaceutical compositions containing nucleotide analogs against platelet aggregetion disorder and process for their preparation | |
GB9007137D0 (en) | Selective inhibition of dna polymerase | |
IL123849A0 (en) | Pharmaceutical composition useful for nucleic acid transfection and use thereof | |
HUP9802741A3 (en) | Pharmaceutical composition containing tiagabine or its salt and the process for its preparation | |
HUP0000572A3 (en) | Pharmaceutical compositions containing nucleotide analogs and process for preparing them | |
EP0639649A3 (en) | Nucleic acid probes to ureaplasma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
RH | Patent void |